hydroxychloroquine

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)

Not yet recruiting
  • Hydroxychloroquine
  • +2 more
  • Hydroxychloroquine Combined With Gemcitabine
  • (no location specified)
Dec 3, 2022

At Heart of Matter - Speckle Tracking Echocardiography in Lupus

Recruiting
  • Systemic Lupus Erythematosus
  • +7 more
    • Montreal, Quebec, Canada
      Montreal General Hospital
    Aug 8, 2022

    Covid-19 Infection, Rheumatoid Arthritis, Psoriatic Arthritis Trial in Edmonton (Hydroxychloroquine/Chloroquine)

    Active, not recruiting
    • Covid-19 Infection
    • +3 more
    • Hydroxychloroquine/Chloroquine
    • Edmonton, Alberta, Canada
      University of Alberta
    Jul 19, 2022

    Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic acid, Low-dose aspirin)

    Recruiting
    • Hydroxychloroquine
    • Assiut, Egypt
      Abdel-rahman Mahmoud Mohammed
    Jul 21, 2021

    Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic Acid, Low-dose aspirin)

    Active, not recruiting
    • Hydroxychloroquine
    • Assiut, Egypt
      Abdel-rahman Mahmoud Mohammed
    Jul 21, 2021

    Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)

    Enrolling by invitation
    • Hydroxychloroquine
    • +3 more
    • Hydroxychloroquine Sulfate
    • Bromhexine 8 MG
    • Mexico City, Cdmx, Mexico
      National Institute of Rehabilitation, Luis Guillermo Ibarra Ibar
    Jun 26, 2021

    COVID19, Hydroxychloroquine, Prophylaxis Trial in Meldola (Hydroxychloroquine)

    Active, not recruiting
    • COVID19
    • +4 more
    • Meldola, FC, Italy
      Irst Irccs
    Feb 11, 2021

    Sars-CoV2, Coronavirus Infection, Prevention & Control Trial (Hydroxychloroquine Only Product in Oral Dose Form)

    Not yet recruiting
    • Sars-CoV2
    • +4 more
    • Hydroxychloroquine Only Product in Oral Dose Form
    • (no location specified)
    Sep 26, 2020

    COVID19, Sars-CoV2, Hydroxychloroquine Trial in Tunis (Hydroxychloroquine (HCQ), Placebo oral tablet)

    Withdrawn
    • COVID19
    • +4 more
    • Hydroxychloroquine (HCQ)
    • Placebo oral tablet
    • Tunis, Tunisia
      Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Aria
    Aug 26, 2020

    COVID-19, SARS-CoV-2, Pregnant Women Trial (hydroxychloroquine sulfate 200 MG, Placebo oral tablet)

    Withdrawn
    • COVID-19
    • +3 more
    • hydroxychloroquine sulfate 200 MG
    • Placebo oral tablet
    • (no location specified)
    Jun 23, 2020

    Ivermectin, Hydroxychloroquine, COVID19 Trial in Cox's Bazar (Ivermectin + Doxycycline, Hydroxychloroquine + Azithromycin)

    Completed
    • Ivermectin
    • +2 more
    • Ivermectin + Doxycycline
    • Hydroxychloroquine + Azithromycin
    • Cox's Bazar, Bangladesh
      Chakoria Upazilla Health Complex
    Jun 14, 2020

    COVID-19, Favipiravir, Kaletra Trial in Tehran (Favipiravir, Hydroxychloroquine, Lopinavir / Ritonavir)

    Completed
    • COVID-19
    • +4 more
    • Tehran, Iran, Islamic Republic of
      Mohammad Sadegh Bagheri Baghdasht
    Jun 12, 2020

    Myocardial Infarction, Acute Coronary Syndrome, Inflammation Trial in Finland (Hydroxychloroquine, Placebo)

    Completed
    • Myocardial Infarction
    • +5 more
    • Helsinki, Finland
    • +5 more
    Jun 6, 2020

    Prophylaxis, COVID-19, Health Care Worker Trial in New York (Hydroxychloroquine Pre-Exposure Prophylaxis, Placebo oral tablet)

    Unknown status
    • Prophylaxis
    • +3 more
    • Hydroxychloroquine Pre-Exposure Prophylaxis
    • Placebo oral tablet
    • New York, New York
      The New York Center for Travel and Tropical Medicine
    Apr 20, 2020

    IgA Patients, Hydroxychloroquine Trial in BeiJing (Hydroxychloroquine Sulfate, Placebo)

    Completed
    • IgA Patients
    • Hydroxychloroquine
    • Hydroxychloroquine Sulfate
    • Placebo
    • BeiJing, Beijing, China
      Peking University First Hospital
    Feb 2, 2018